Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
CLPBY COLOPLAST SPON ADS EACH REPR 0.1 OD SHS
12.230
+0.190+1.58%
NamePositionSalaryService DateEducationAgeGenderUpdated
Mr. Kristian VillumsenPresident and Chief Executive Officer------52male11/07/2022
Mr. Anders Lonning-SkovgaardExecutive Vice President and Chief Financial Officer------50male11/07/2022
Mr. Lars RasmussenChairman of the Board------63male11/07/2022
Mr. Niels Peter Louis-HansenDeputy Chairman of the Board------75male11/07/2022
Mr. Thomas BarfodDirector------52male11/07/2022
Mr. Roland V. PedersenDirector------60male11/07/2022
Mr. Nikolaj Kyhe GundersenDirector------43male11/07/2022
Mr. Carsten HellmannIndependent Director------58male11/07/2022
Ms. Marianne WiinholtIndependent Director------57female11/07/2022
Ms. Jette Nygaard-AndersenIndependent Director------44female11/07/2022
Company Overview More
Coloplast A/S develops, manufactures, and markets medical products. It operates through the following segments: Chronic Care, Interventional Urology and Wound & Skin Care. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Interventional Urology segment covers the sale of urological products, including disposable products. The Wound & Skin Care segment covers the sale of wound and skin care products. The company was founded by Aage Louis-Hansen and Johanne Louise-Hansen in 1954 and is headquartered in Humlebaek, Denmark.
CEO: Mr. Kristian Villumsen
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist